Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) – a clinicopathological study

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Leukemia

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.leu.2401553PMID 10557047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis.

  2009cited by this paper
• Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - correlations between clinical and morphological features

  2004cited by this paper
• Myelofibrosis with myeloid metaplasia.

  2000cited by this paper
• Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.

  1999cited by this paper
• Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groups

  1998cited by this paper
• The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades

  1998cited by this paper
• Proposal for Revised Diagnostic Criteria of Essential Thrombocythemia and Polycythemia Vera by the Thrombocythemia Vera Study Group

  1997cited by this paper
• Identification of ‘short‐lived’ and ‘long‐lived’ patients at presentation of idiopathic myelofibrosis

  1997cited by this paper
• Prognostic factors in idiopathic (Primary) osteomyelofibrosis

  1997cited by this paper
• Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases

  1997cited by this paper
• Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.

  1997cited by this paper
• Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.

  1996cited by this paper
• Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.

  1996cited by this paper
• Hematopathologic findings in the myeloproliferative disorders.

  1995cited by this paper
• The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update.

  1995cited by this paper
• TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.

  1995cited by this paper
• Agnogenic myeloid metaplasia.

  1995cited by this paper
• The prevalence of cognitive distortion in depressed adolescents.

  1995cited by this paper
• Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival

  1994cited by this paper
• Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.

  1994cited by this paper
• Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.

  1993cited by this paper
• Idiopathic myelofibrosis — an update with particular reference to clinical aspects and prognosis

  1993cited by this paper
• Pathogenesis of idiopathic myelofibrosis: role of growth factors.

  1992cited by this paper
• Life expectancy of patients with chronic nonleukemic myeloproliferative disorders

  1991cited by this paper
• A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis

  1991cited by this paper
• Chronic myeloproliferative disorders in bone marrow biopsies.

  1990cited by this paper
• Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients

  1990cited by this paper
• Idiopathic myelofibrosis: a retrospective study of 103 patients.

  1990cited by this paper
• Bone marrow histopathology in primary myelofibrosis: Clinical and haematologic correlations and prognostic evaluation

  1990cited by this paper
• Reversal of myelofibrosis by hydroxyurea

  1990cited by this paper
• PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA

  1989cited by this paper
• Myelofibrosis: A concise review of clinical and pathologic features and treatment

  1988cited by this paper
• The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens

  1988cited by this paper
• Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.

  1988cited by this paper
• A prognostic classification of myelofibrosis with myeloid metaplasia

  1988cited by this paper
• Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis

  1986cited by this paper
• Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.

  1985cited by this paper
• Effect of alkylating agents on hematopoiesis in myelofibrosis. 4 case report.

  1984cited by this paper
• Progressive myelofibrosis in agnogenic myeloid metaplasia.

  1983cited by this paper
• The Syndrome of Idiopathic Myelofibrosis: A CLINICOPATHOLOGIC REVIEW WITH EMPHASIS ON THE PROGNOSTIC VARIABLES PREDICTING SURVIVAL

  1983cited by this paper
• Bone marrow biopsy with unaltered architecture: a new biopsy device.

  1971cited by this paper
• Agnogenic myeloid metaplasia

  1957cited by this paper

• Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future

  2025cites this paper
• Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification

  2025cites this paper
• SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis.

  2024cites this paper
• Quantitative interpretation of bone marrow biopsies in MPN—What's the point in a molecular age?

  2023cites this paper
• Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

  2023cites this paper
• Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approach.

  2022cites this paper
• Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis

  2021cites this paper
• [Myelofibrosis: A review].

  2020cites this paper
• Prefibrotic myelofibrosis: treatment algorithm 2018

  2018cites this paper
• The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

  2018cites this paper
• Myeloproliferative and “Overlap” Myelodysplastic/Myeloproliferative Neoplasms

  2018cites this paper
• Diagnosis and management of prefibrotic myelofibrosis

  2018cites this paper
• What is pre‐fibrotic myelofibrosis and how should it be managed in 2018?

  2018cites this paper
• Thrombocytosis and thrombocythemia

  2018cites this paper
• Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

  2017cites this paper
• Acquired Von Willebrand Syndrome (AVWS) Type 2A as the Presenting Feature of JAK2 Wild type Thrombocythemia in a Child: Effectiveness of Platelet Reduction by Anagrelide

  2017cites this paper
• The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances.

  2016cites this paper
• Advances and challenges in the management of essential thrombocythemia

  2015cites this paper
• Myeloproliferative Neoplasm with Extensive Myeloid Metaplasia: A Diagnostic Dilemma

  2015influential citation
• Interferon therapy for myelofibrosis

  2015cites this paper
• Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

  2015cites this paper
• BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.

  2015cites this paper
• Myeloproliferative neoplasia : more insight in the pathogenesis

  2014cites this paper
• Relationship between the 46/1 haplotype of the JAK2 gene and the JAK2 mutational status and allele burden, the initial findings, and the survival of patients with myelofibrosis

  2014cites this paper
• Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms

  2014cites this paper
• Development of bead‐based suspension array technology for the diagnosis of thalassemia

  2014cites this paper
• Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis

  2014cites this paper
• and Treatment study of the International Working Group for Myelofibrosis Research New prognostic scoring system for primary myelofibrosis based on a

  2013cites this paper
• myeloproliferative disorders and constitutive mobilization of CD34+ cells into peripheral blood in Relation between JAK2 (V617F) mutation status, granulocyte activation,

  2013cites this paper
• Pharmacological management of essential thrombocythemia

  2013cites this paper
• reliability and utility for identifying disease subtypes Bone marrow pathology in essential thrombocythemia: interobserver

  2013cites this paper
• the V617F JAK-2 mutation Ph-negative chronic myeloproliferative diseases and is independent of Different STAT-3 and STAT-5 phosphorylation discriminates among

  2013cites this paper
• Critical Issues About the Diagnosis of MPNs: Bone Marrow Histopathology

  2012cites this paper
• Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis

  2012cites this paper
• Idiopathic myelofibrosis mimicking hemolytic anemia

  2012cites this paper
• Critical Issues About the Diagnosis of Myeloproliferative Neoplasms: World Health Organization Classification

  2012cites this paper
• Idiopathic myelofibrosis mimicking hemolytic

  2012cites this paper
• Myeloproliferative Neoplasien

  2012cites this paper
• Diagnosis and Classification of the BCR-ABL1-Negative Myeloproliferative Neoplasms

  2011cites this paper
• Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis

  2010cites this paper
• Primary myelofibrosis: update on definition, pathogenesis, and treatment.

  2009cites this paper
• Thrombosis in primary myelofibrosis: incidence and risk factors.

  2009cites this paper
• Prodromal myeloproliferative neoplasms: The 2008 WHO classification

  2009cites this paper
• Philadelphia chromosome-negative chronic myeloproliferative disease.

  2009cites this paper
• Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.

  2008cites this paper
• Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

  2008cites this paper
• Prefibrotic myelofibrosis: is this diagnosis valid?

  2008cites this paper
• New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

  2008cites this paper
• Amino acids and the erythrocyte under stress

  2008cites this paper
• Chronic Idiopathic Myelofibrosis

  2007cites this paper
• Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations

  2007cites this paper
• Myelofibrosis – What’s in a Name?

  2007cites this paper
• Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).

  2007cites this paper
• Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation.

  2007cites this paper
• Classification of Ph-Negative Chronic Myeloproliferative Disorders – Morphology as the Yardstick of Classification

  2007cites this paper
• Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.

  2006cites this paper
• The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.

  2006cites this paper
• Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

  2006cites this paper
• Megakaryocytic features useful for the diagnosis of myeloproliferative disorders can be obtained by a novel unsupervised software analysis.

  2006cites this paper
• Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.

  2006influential citation
• Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histology

  2006cites this paper
• Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders.

  2006cites this paper
• The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.

  2006cites this paper
• Grade of bone marrow fibrosis is associated with relevant hematological findings—a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis

  2006cites this paper
• A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders

  2006cites this paper
• The 2001 World Health Organization and Updated European Clinical and Pathological Criteria for the Diagnosis, Classification, and Staging of the Philadelphia Chromosome-Negative Chronic Myeloproliferative Disorders

  2006cites this paper
• The Impact of Clinicopathological Studies on Staging and Survival in Essential Thrombocythemia, Chronic Idiopathic Myelofibrosis, and Polycythemia Rubra Vera

  2006cites this paper
• Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution

  2006cites this paper
• Clinicopathological Criteria for Differential Diagnosis of Thrombocythemias in Various Myeloproliferative Disorders

  2006cites this paper
• Illustrated pathology of the bone marrow

  2006cites this paper
• Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined.

  2006cites this paper
• Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis.

  2006cites this paper
• Trisomy 8 in Prefibrotic Early Stages of Chronic Idiopathic Myelofibrosis: A Fluorescence in situ Study of Bone Marrow Biopsies

  2006cites this paper
• Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.

  2005cites this paper
• Trombocytózy a trombocytémie

  2005cites this paper
• Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic–granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders

  2005cites this paper
• Idiopathic myelofibrosis.

  2005cites this paper
• Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond

  2005cites this paper
• Marrow Histopathology in Myeloproliferative isorders — Current Diagnostic Approach

  2005cites this paper
• Hematopathologic findings in chronic idiopathic myelofibrosis.

  2005cites this paper
• Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and staging.

  2005cites this paper
• Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.

  2005cites this paper
• Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool

  2005cites this paper
• NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.

  2005cites this paper
• Chronic Myeloproliferative Disorders: A Pathologist’s View

  2004cites this paper
• Doctor's Brochure 2004 Myeloproliferative Disorders: MPDs Essential Thrombocythemia: ET Polycythemia Vera: PV Chronic Idiopathic Myelofibrosis: IMF

  2004cites this paper
• Analysis of Risk Factors of the Evolution of Myelofibrosis in Pre-Fibrotic Chronic Idiopathic Myelofibrosis: A retrospective study based on follow up biopsies of 70 patients by using the RECPAM method

  2004cites this paper
• Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.

  2004cites this paper
• Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.

  2004cites this paper
• Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients

  2003cites this paper
• Dynamics of Fibrosis in Chronic Idiopathic (Primary) Myelofibrosis During Therapy: A follow-up Study on 309 Patients

  2003cites this paper
• Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis

  2003cites this paper
• Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. an immunohistochemical and morphometric study of sequential trephine biopsies.

  2003cites this paper
• Pathology of the myeloproliferative diseases.

  2003cites this paper
• The World Health Organization (WHO) Classification of the Myeloid Neoplasms

  2002cites this paper
• Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia)

  2002cites this paper
• Die Entwicklung der Myelofibrose bei der "präfibrotischen"cIMF

  2002cites this paper
• The World Health Organization (WHO) classification of the myeloid neoplasms.

  2002cites this paper
• CD34+ stem cells in chronic myeloproliferative disorders.

  2002cites this paper
• [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].

  2002cites this paper